News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Galip Can Uyar: Telehealth-Delivered Geriatric Assessment Makes a Difference
Galip Can Uyar/LinkedIn
Jun 13, 2025, 05:44

Galip Can Uyar: Telehealth-Delivered Geriatric Assessment Makes a Difference

Galip Can Uyar, Medical Oncologist at Etlik City Hospital, posted on X:

“Telehealth-Delivered Geriatric Assessment Makes a Difference!

The GAIN-S RCT in older adults with metastatic cancer showed:

  • High IADL: +1.8
  • Low Depression (GDS): –2.7
  • High Quality of life (FACT-G): +13.2
  • All in just 3 months — all statistically significant (p<.001).”

Title: Telehealth Geriatric Assessment and Supportive Care Intervention (GAIN-S) Program: A Randomized Clinical Trial

Authors: Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Marianne Razavi, Marcos Vinicius da Silva França, Jonas Ribeiro Gomes da Silva, Jose Adolfo Cerveira, William Hiromi Fuzita, Andressa Cardoso de Azeredo, Gabriel Marques dos Anjos, Vitor Fiorin de Vasconcellos, Errol J. Philip, João Nunes de Matos Neto, Jorge Fernandes Canedo, Mariana Tosello Laloni, Carlos Gil Moreira Ferreira, Marco Murilo Buso, Sumanta K. Pal, Ryan Nipp, Areej El-Jawahri, Enrique Soto-Perez-de-Celis, William Dale

Read The Full Article at JNCCN.

Galip Can Uyar: Telehealth-Delivered Geriatric Assessment Makes a Difference

More posts featuring Geriatric Oncology.

Andressa Cardoso de Azeredo Areej El-Jawahri cancer Carlos Gil Moreira Ferreira Cristiane Decat Bergerot Enrique Soto Perez de Celis Errol J. Philip Gabriel Marques dos Anjos Galip Can Uyar Geriatric Assessment Geriatric Oncology João Nunes de Matos Neto Jonas Ribeiro Gomes da Silva Jorge Fernandes Canedo Jose Adolfo Cerveira Marco Murilo Buso Marcos Vinicius da Silva França Mariana Tosello Laloni Marianne Razavi OncoDaily Oncology Paulo Gustavo Bergerot Ryan Nipp Sumanta K. Pal Vitor Fiorin de Vasconcellos William Dale William Hiromi Fuzita
Special Coverage
Blog
Jun 13, 2025, 05:44
Galip Can Uyar: Telehealth-Delivered Geriatric Assessment Makes a Difference
Blog
Jun 13, 2025, 05:35
Jorge Cortes: The First Issue of Blood Global Hematology is Out
Insight
Jun 13, 2025, 05:15
Yuji Uehara: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC
Insight
Jun 13, 2025, 04:29
MD Anderson Research Highlights
Drugs
Jun 13, 2025, 04:16
Pemigatinib (Pemazyre): Uses in Cancer, Side effects, Dosage, Expectation and more
Insight
Jun 13, 2025, 03:49
Diego A. Díaz García shared an article on roles of the gut microbiota in immune-related adverse events - mechanisms and therapeutic intervention
Oncolibrary
Jun 13, 2025, 03:18
Etiology: Understanding the Causes and Origins of Disease
Insight
Jun 12, 2025, 19:31
Amar Kishan: UCLA Launches ILLUSION Trial on 2 mm PTV Margins in CT-Guided SBRT
Insight
Jun 12, 2025, 19:16
Eric K. Singhi: U.S. FDA Approved Taletrectinib for ROS1+ mNSCLC
Insight
Jun 12, 2025, 19:07
Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials
Blog
Jun 12, 2025, 18:57
Edward Christopher Dee and Layal Al Mahmasani Highlighted Participation in Inaugural Global Oncology Trainee Track at MSK
Blog
Jun 12, 2025, 18:40
Register for the 2nd National Cancer Summit - National Cancer Institute of Kenya